Sylentis
Pre-clinicalOur Mission is to discover new ways to improve and extend people’s vision. We look to the future to inspire us and work to lead medicine toward new horizons.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $60M
About
Our Mission is to discover new ways to improve and extend people’s vision. We look to the future to inspire us and work to lead medicine toward new horizons.
RNA & Gene Therapy
Funding History
3Total raised:$60M
Series C$30MJun 15, 2016
Series B$20MJun 15, 2013
Series A$10MJun 15, 2010